{"output": [["Five Prime Therapeutics Inc", "COMP", "Earns", "Milestone Payment", "ECON_INDICATOR"], ["Five Prime Therapeutics Inc", "COMP", "Collaborate", "Bristol-Myers Squibb", "ORG"], ["Bristol-Myers Squibb", "ORG", "Announce", "Extend Research Term", "CONCEPT"], ["Five Prime Therapeutics Inc", "COMP", "Operate_In", "Immune Checkpoint Pathways Discovery", "CONCEPT"], ["Five Prime Therapeutics Inc", "COMP", "Relate_To", "Antibody Targeting TIM-3", "CONCEPT"], ["Five Prime Therapeutics Inc", "COMP", "Receive", "Additional Funding", "ECON_INDICATOR"], ["Bristol-Myers Squibb", "ORG", "Provide", "Additional Funding", "ECON_INDICATOR"]], "published": "2018-01-08T22:05:00.000+02:00"}